Patent · US Active

Pharmaceutical preparation of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide

US8784887B2 · kind B2 · utility

13Cited by

8References

17Claims

0Family size

Assignee

AiCuris GmbH & Co. KG · DE

Inventors

Tobias Laich · Cologne, DE
Katrin Liebelt · Glückstadt, DE

Key dates

Filing date	Sep 27, 2007
Grant date	Jul 22, 2014
Priority date	—
Expiry date	Jan 24, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a pharmaceutical preparation for oral administration comprising N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide or its hydrates and/or solvates, as well as an acid, a method for its production as well as the use of this preparation for the treatment and/or prophylaxis of diseases which are caused by herpes viruses, in particular diseases which are caused by herpes simplex viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.